| Literature DB >> 30364294 |
Gregory M Taylor1, Diane M Paratore1.
Abstract
Acute bacterial prostatitis, an acute infection of the prostate gland, results in lower abdominal pain, flank pain, urinary symptoms and the potential for systemic symptoms like fever and shock. With a high mortality rate if left untreated, acute bacterial prostatitis becomes a true urological emergency, which if allowed to progress, may result in bacteremia, severe sepsis/septic shock and death. Diagnosis is mainly clinical with a detailed history and physical and laboratory evaluation to include a urinalysis. However, imaging may be necessary to exclude other pathology. We present the case of a 44-year-old male with a history of well-controlled HIV that used a prostate vibrator for 1-week prior to his presentation to the ED. He was subsequently diagnosed with septic shock secondary to acute bacterial prostatitis and required ICU management.Entities:
Year: 2018 PMID: 30364294 PMCID: PMC6194185 DOI: 10.1093/omcr/omy086
Source DB: PubMed Journal: Oxf Med Case Reports ISSN: 2053-8855
Figure 1:Ultrasound of the scrotum with Doppler revealed a prominent epididymis with increased vascularity in addition to a small left hydrocele. Sonographic findings were consistent with a left epididymitis and an associated left hydrocele (a). CT of the abdomen/pelvis without contrast was performed revealing left-sided peri-ureteral fat stranding, a prominent left seminal vesicle, with infiltrative fat stranding predominantly centered around the left hemi-pelvis with multiple prominent pelvic lymph nodes up to 8.1 mm within the right iliac chain including prominent inguinal lymph nodes up to 6.5 mm (b and c). The prostate is top-normal in size at 5 cm (d). Sonographic findings were consistent with inflammatory changes within the left hemi-pelvis with prominence of the left seminal vesicle and prostate favored to be secondary to prostatitis.
Sensitivity of various bacterial strains to common antibiotics in patients diagnosed with acute bacterial prostatitis. Figures in parentheses represent the total number (n) of cases identified in the retrospective study [9]
| Ampicillin | 73.8 | – | – | – | 50 | – | 33.3 | – |
| Amoxicillin + Clavulanic acid | 86.4 | – | 33.3 | – | 75 | – | 66.6 | – |
| Ampicillin + Sulbactam | 84.5 | 20 | 33.3 | 83.3 | 75 | – | 66.6 | 50 |
| Piperacillin + Tazobactam | 95.2 | 100 | 66.6 | 100 | 75 | 66.6 | – | 50 |
| Cefuroxime | 95.2 | – | 33.3 | – | 50 | 33.3 | – | – |
| Cefepime | 98.1 | 60 | 33.3 | 100 | 75 | 66.6 | – | 100 |
| Ciprofloxacin | 92 | 50 | 33.3 | 83.3 | 50 | 66.6 | – | 50 |
| Gentamycin | 100 | 80 | 33.3 | 100 | 75 | 100 | – | 100 |
| Tobramycin | 98.1 | 80 | 33.3 | 100 | 75 | 100 | – | 100 |
| Amikacin | 100 | 80 | 100 | 100 | 100 | 100 | – | 100 |
| Imipenem | 100 | 100 | 100 | 100 | 100 | 100 | – | 100 |
| Aztreonam | 98.1 | 100 | 33.3 | 100 | 100 | – | – | 100 |
| Vancomycin | – | – | – | – | – | – | 100 | – |